Skip to main content

Carol Fabian, MD


Publications: Click here

Rank: Professor Emeritus
Position: Chair, Cancer Prevention Research Program
Position: Director, Breast Cancer Prevention Center
Position: Director, Breast Cancer Survivorship Center
Position: Kansas Masonic Research Endowed Chair


Clinical Interests

Breast Cancer Treatment | Breast Cancer Prevention | Breast Cancer

Research Interests

Development and utilization of tissue-based biomarkers for prediction, prevention, and detection of breast cancer; for use in the conduct of Phase I and II clinical trials of potential breast cancer chemoprevention agents.


Education and Training

Medical school: University of Kansas School of Medicine
Internship: Wesley Medical Center, Wichita, KS
Residency: Department of Internal Medicine, Wesley Medical Center
Fellowship: Clinical Oncology, University of Kansas Medical Center


Awards

  • American Cancer Society Recognition Award for Outstanding Achievements
  • Best Doctors in America and Central Region
  • Named in "Top Cancer Specialists for Women" Good Housekeeping
  • University of Kansas Medical Center Faculty Research Award
  • Selected as one of the "Top Breast Cancer Specialists" Redbook
  • Selected as one of the "Best Docs for Women" Ladies Home Journal
  • Selected as one of the "Best Doctors in Kansas City" KC Magazine
  • Rose Blumkin Award for Excellence for Leadership in the Fight Against Breast Cancer
  • AstraZeneca Visions of Hope Award
  • Kansas City's Heroes in Healthcare, Ingrams Magazine
  • University of Kansas Distinguished Professor

Organizations

  • American College of Physicians
  • American Society of Breast Disease
  • American Society of Preventive Oncology
  • International Society of Cancer Chemoprevention
  • American Society of Human Genetics
  • International Society of Cancer Risk Assessment and Management
  • American Association for Cancer Research
  • American Society of Clinical Oncology (ASCO)
  • Southwest Oncology Group (SWOG)

Publications

  • Visvanathan K, Fabian CJ, Bantug E, Brewster AM, Davidson NE, DeCensi A, Floyd JD, Garber JE, Hofstatter EW, Khan SA, Katapodi MC, Pruthi S, Raab R, Runowicz CD, Somerfield MR. Use of endocrine therapy for breast cancer risk reduction: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2019 Nov 20;37(33):3152-3165. PMID: 31479306
  • Fabian CJ, Visvanathan K, Somerfield MR. Use of endocrine therapy for breast cancer risk reduction: ASCO Clinical Practice Guideline Update Summary. J Oncol Pract. 2019 Nov;15(11):607-610. PMID: 31479308
  • Befort CA, Kimler BF, Bantis LE, Phillips TA, Fabian CJ. Effects of weight loss and weight regain on circulating biomarkers in overweight/obese breast cancer survivors enrolled in a weight loss trial in the rural Midwest. Cancer Epidemiol Biomark Prev 2020; 29:1321-1328. PMID: 32307097
  • Fabian CJ, Khan SA, Garber JE, Dooley WC, Yee LD, Klemp JR, Nydegger JL, Powers KR, Kreutzjens AL, Zalles CM, Metheny T, Phillips TA, Hu J, Koestler DC, Chalise P, Kumar Yellapu N, Jernigan C, Petroff BK, Hursting SD, Kimler BF.  Randomized phase IIB trial of the lignan secoisolariciresinol diglucoside in pre-menopausal women at increased risk for development of breast cancer. Cancer Prev Res 2020; 13:623-634. PMID: 32312713 
Last modified: Feb 18, 2021

Carol Fabian, MD

Contact

Carol Fabian, MD

Professor of Medicine Chair, Cancer Prevention Research Program Director, Breast Cancer Prevention Center Director, Breast Cancer Survivorship Center Kansas Masonic Research Endowed Chair

P: 913-588-1227

Make an appointment

ID=x8848